These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29879026)

  • 1. Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports.
    Li Q; Zhao F; Ju Y
    Medicine (Baltimore); 2018 Jun; 97(23):e10894. PubMed ID: 29879026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Stolarova L; Kleiblova P; Janatova M; Soukupova J; Zemankova P; Macurek L; Kleibl Z
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preimplantation diagnosis for neurofibromatosis.
    Verlinsky Y; Rechitsky S; Verlinsky O; Chistokhina A; Sharapova T; Masciangelo C; Levy M; Kaplan B; Lederer K; Kuliev A
    Reprod Biomed Online; 2002; 4(3):218-22. PubMed ID: 12709270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
    Wang N; Ding H; Liu C; Li X; Wei L; Yu J; Liu M; Ying M; Gao W; Jiang H; Wang Y
    Oncogene; 2015 Oct; 34(40):5198-205. PubMed ID: 25619829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
    Fan Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
    Breast Cancer Res Treat; 2018 May; 169(1):59-67. PubMed ID: 29356917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.
    Mohamad S; Isa NM; Muhammad R; Emran NA; Kitan NM; Kang P; Kang IN; Taib NA; Teo SH; Akmal SN
    PLoS One; 2015; 10(1):e0117104. PubMed ID: 25629968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
    Yoo SJ; Hwang YS
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
    Menon AG; Gusella JF; Seizinger BR
    Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
    Trevisson E; Forzan M; Salviati L; Clementi M
    Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
    Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
    Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
    Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J
    Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mutations in the NF2 gene in Polish patients with neurofibromatosis type 2.
    Łaniewski-Wołłk M; Gos M; Koziarski A; Szpecht-Potocka A
    J Appl Genet; 2008; 49(3):297-300. PubMed ID: 18670066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
    Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
    Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Germline
    Zhao Y; Yu T; Chen L; Xie D; Wang F; Fu L; Cheng C; Li Y; Zhu X; Miao G
    Thyroid; 2020 Jun; 30(6):924-930. PubMed ID: 32041497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.
    Schroeder RD; Angelo LS; Kurzrock R
    Oncotarget; 2014 Jan; 5(1):67-77. PubMed ID: 24393766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The R1947X mutation of NF1 causing autosomal dominant neurofibromatosis type 1 in a Chinese family.
    Yang Q; Huang C; Yang X; Feng Y; Wang Q; Liu M
    J Genet Genomics; 2008 Feb; 35(2):73-6. PubMed ID: 18407053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline
    Thibodeau ML; Reisle C; Zhao E; Martin LA; Alwelaie Y; Mungall KL; Ch'ng C; Thomas R; Ng T; Yip S; J Lim H; Sun S; Young SS; Karsan A; Zhao Y; Mungall AJ; Moore RA; J Renouf D; Gelmon K; Ma YP; Hayes M; Laskin J; Marra MA; Schrader KA; Jones SJM
    Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28514723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.